These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 10436549

  • 21. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR, Sader HS, Stilwell MG, Dowzicky MJ, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [Abstract] [Full Text] [Related]

  • 22. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.
    Piéboji JG, Koulla-Shiro S, Ngassam P, Adiogo D, Njine T, Ndumbe P.
    Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Current status of resistance of bacteria to pefloxacin in hospital units. Cross resistance with ofloxacin and ciprofloxacin. Results of a multicenter study].
    Thabaut A, Meyran M, Fabre R, Dellamonica P, Moreau N.
    Pathol Biol (Paris); 1994 May; 42(5):369-74. PubMed ID: 7824298
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antimicrobial resistance patterns of clinical bacterial isolates in southwestern Ethiopia.
    Gebre-Sealsssie S.
    Ethiop Med J; 2007 Oct; 45(4):363-70. PubMed ID: 18326346
    [Abstract] [Full Text] [Related]

  • 31. Community acquired bacterial infections and their antimicrobial susceptibility in Nairobi, Kenya.
    Malonza IM, Omari MA, Bwayo JJ, Mwatha AK, Mutere AN, Murage EM, Ndinya-Achola JO.
    East Afr Med J; 1997 Mar; 74(3):166-70. PubMed ID: 9185414
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer.
    Rolston KV, Ho DH, LeBlanc B, Streeter H, Dvorak T.
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():15-22. PubMed ID: 9222065
    [Abstract] [Full Text] [Related]

  • 36. Susceptibility of corneal and conjunctival pathogens to ciprofloxacin.
    Knauf HP, Silvany R, Southern PM, Risser RC, Wilson SE.
    Cornea; 1996 Jan; 15(1):66-71. PubMed ID: 8907383
    [Abstract] [Full Text] [Related]

  • 37. Current state and tendencies of antibiotic resistance in Hungary.
    Thege MK, Bán E.
    Acta Microbiol Hung; 1986 Jan; 33(2):157-70. PubMed ID: 3811828
    [Abstract] [Full Text] [Related]

  • 38. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
    Biedenbach DJ, Toleman M, Walsh TR, Jones RN.
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):13-21. PubMed ID: 16290025
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.